Literature DB >> 9517364

Health technology assessment--the role of the pharmaceutical panel.

T Walley1, M Rawlins, K Stein.   

Abstract

Mesh:

Year:  1998        PMID: 9517364      PMCID: PMC1873366          DOI: 10.1046/j.1365-2125.1998.00678.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Newly licensed drugs.

Authors:  R E Ferner
Journal:  BMJ       Date:  1996-11-09

2.  The prostate question, unanswered still.

Authors: 
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

Review 3.  Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.

Authors:  J Chamberlain; J Melia; S Moss; J Brown
Journal:  Br J Urol       Date:  1997-05

4.  Science in a health service.

Authors:  J D Swales
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

5.  Screening for prostate cancer.

Authors:  J Swales; G Winyard
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

6.  Drug prescribing--the concern of all.

Authors:  P A Parish
Journal:  R Soc Health J       Date:  1973-08

Review 7.  Diagnosis, management and screening of early localised prostate cancer.

Authors:  S Selley; J Donovan; A Faulkner; J Coast; D Gillatt
Journal:  Health Technol Assess       Date:  1997       Impact factor: 4.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.